WASHINGTON (AP) — Makers of medical tests that have long escaped government oversight will have about four years to show that their new offerings deliver accurate results, under a government rule vigorously opposed by the testing industry. The regulation finalized Monday by the Food and Drug Administration will gradually phase in oversight of new tests developed by laboratories, a multibillion-dollar industry that regulators say poses growing risks to Americans. The goal is to ensure that new tests for cancer, heart disease, COVID-19, genetic conditions and many other illnesses are safe, accurate and reliable. “The final rule announced today aims to provide crucial oversight of these tests to help ensure that important health care decisions are made based on test results that patients and health care providers can trust,” said FDA commissioner Robert Califf, in a release. |
Gossiping cats, a headless horse and a kung fuJust Stop Oil ecoBetting money for the WNBA is pouring in on Caitlin Clark and the Indiana FeverDR MICHAEL MOSLEY: Why eating at a snail's pace works like OzempicMy husband died in a snorkeling accident in HawaiiFormer United States Olympic and Michigan swim coach Jon Urbanchek dies at 87Former Alabama pitcher Montana Fouts to join Athletes Unlimited for AUX seasonPandemic treaty: Countries struggle to plan to avoid mistakes made during COVIDSweetgreen says cleaner farming method will offset adding steak to its menuEverton drops appeal against Premier League points deduction after staving off relegation